Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2004 Oct;42(10):4893–4896. doi: 10.1128/JCM.42.10.4893-4896.2004

Mitral Bioprosthetic Valve Endocarditis Caused by an Unusual Microorganism, Gemella morbillorum, in an Intravenous Drug User

Ramzan M Zakir 1, Anthony Al-Dehneh 1, Leticia Dabu 1, Raj Kapila 1, Muhamed Saric 1,*
PMCID: PMC522326  PMID: 15472375

Abstract

We report a case of Gemella morbillorum mitral bioprosthetic valve endocarditis with perivalvular extension in a 44-year-old human immunodeficiency virus-positive man who is an active intravenous drug user together with review of all published cases. This is only the second reported case of Gemella morbillorum endocarditis in a patient with a prosthetic valve.

CASE REPORT

A 44-year-old human immunodeficiency virus-positive man with a history of active intravenous drug use and a mitral valve replacement only 9 months earlier for native-valve endocarditis due to Staphylococcus aureus was admitted complaining of pleuritic chest pain, shortness of breath, fever, and chills.

Physical examination revealed a temperature of 99.8°F, blood pressure of 114/70 mm Hg, a regular heat rate at 98 beats per min, and a grade III/VI holosystolic murmur radiating to the axilla. No clinical signs of congestive heart failure (such as pulmonary rales or peripheral edema) were noted.

An electrocardiogram was notable for a first-degree atrioventricular block (an increased PR interval of 0.22 s) and nonspecific T wave changes. Laboratory investigations were significant for a normocytic anemia with a hemoglobin level of 10.9 g/dl and an elevated erythrocyte sedimentation rate of 108 mm per h. However, neither the total white blood cell count nor the percentage of banded neutrophils was elevated (3.72 × 109/liter and 4% bands, respectively).

Three sets of blood cultures were obtained prior to initiating antibiotic therapy. Blood samples were incubated in a continuous-monitoring culture system (Bac T/Alert; Becton Dickinson, Organon Teknika, Durham, N.C.) at 37°C. After 24 h of incubation, growth in the anaerobic bottle was noted. The samples were then subcultured at 37°C on MacConkey's agar, sheep blood agar, anaerobic CDC blood agar, and chocolate agar incubated in CO2.

After 24 h of subculture incubation, an alpha-hemolytic organism grew on all plates except the MacConkey agar. The organism was further characterized as being a gram-positive coccus that was both catalase and bile solubility negative.

These initial findings suggested that the organism was Streptococcus viridans. However, on further evaluation with an API 20 streptococcus identification system (Bio Merieux, Vitek Inc., Hazelwood, Mo.), the organism was identified as Gemella morbillorum with 98% confidence.

Antimicrobial susceptibility by disk diffusion method showed the organism to be sensitive to ceftriaxone, clindamycin, levofloxacin, tetracycline, and vancomycin, while the Etest showed sensitivity to penicillin G.

A transthoracic echocardiogram revealed severe regurgitation through incompetent leaflets of the bioprosthetic mitral valve. On spectral Doppler recording of the prosthetic inflow, a severely elevated mean diastolic gradient of 22 mm Hg at a sinus heart rate of 75 beats per min was noted. Since there were no echocardiographic signs of prosthetic stenosis (the pressure half-time was only 77 ms), this gradient was indicative of severely elevated left atrial pressure due to severe mitral regurgitation. In addition, there was moderate central aortic insufficiency.

The left atrium was enlarged (5.3 cm in diameter), as was the left ventricle (end diastolic diameter of 5.8 cm). The left ventricular ejection fraction was high normal (65 to 70%). The imaging of the right side of the heart revealed moderate tricuspid regurgitation and elevation of right atrial (>20 mm Hg) and pulmonary artery systolic (>45 mm Hg) pressures.

On a subsequent transesophageal echocardiogram the prosthetic leaflets were thickened and studded with globular echo densities consistent with vegetations (Fig. 1). In addition, they were misshapen, leading to failure of leaflet coaptation and transvalvular regurgitation.

FIG. 1.

FIG. 1.

Transesophageal echocardiogram of infected mitral bioprosthesis. The leaflets of the mitral bioprosthesis (arrow) are thickened and studded with globular echo densities consistent with vegetations. On color Doppler (not shown), there was severe transvalvular mitral regurgitation. LA, left atrium; LV, left ventricle.

However, between the mitral prosthetic ring and the noncoronary cusp of the native aortic valve there was a 1-cm septated echo lucency with a fistulous tract between the left ventricular outflow tract and the left atrium, seen on color Doppler imaging. These findings were consistent with a paravalvular abscess (Fig. 2). However, there was no paravalvular mitral regurgitation.

FIG. 2.

FIG. 2.

Transesophageal echocardiogram of paraprosthetic abscess. Extending from the mitral bioprosthetic ring and adjacent to the native aortic valve (AV) there is a septated echo-free space (arrows), a finding indicative of abscess formation. LA, left atrium; RA, right atrium.

This patient met multiple Duke criteria for a definite diagnosis of infectious endocarditis. He met two major criteria (new valvular regurgitation and positive echocardiogram) and two minor criteria (predisposing factor of intravenous drug use and a blood culture growing an organism that does not commonly cause endocarditis).

Based on the findings of severe prosthetic mitral regurgitations and a likely paraprosthetic abscess in the setting of PR prolongation on an electrocardiogram, the patient was considered for repeat valvular surgery. However, given the patient's active drug use and a high intraoperative risk, the patient was treated instead medically with ceftriaxone for 4 weeks, with gentamicin added during the first 2 weeks of therapy. Subsequent blood cultures on therapy were all negative.

Discussion.

Gemella morbillorum, formally Streptococcus morbillorum, is a catalase-negative, facultatively anaerobic gram-positive coccus that was first described in 1917 by Tunnicliff (25).

In 1988, the organism was transferred to its present genus based on DNA homology, physiologic properties, and 16S RNA cataloguing (16). It is part of the commensal flora of the oropharynx, gastrointestinal tract, and genitourinary tract and an infrequent cause of infection. Although there have been reports of Gemella morbillorum causing bacteremia and localized infections such as meningitis (9, 13), arthritis (22, 27), abscesses (6, 23), and septic shock (10), the organism is most commonly associated with infectious endocarditis.

Some 22 cases of endocarditis caused by Gemella morbillorum have been reported in English previously, with the vast majority involving native (nonprosthetic) valves. (Table 1) (1-5, 7, 8, 11, 12, 14, 15, 17-22, 24, 26, 28).

TABLE 1.

Summary of all reported cases of Gemella morbillorum endocarditisa

Type of endo- carditis and case no. Age (yr)/ sex Preexisting cardiac lesion Cardiac structure involved in IE Presumed source of organism Treatment Bacteriologic outcome Source or reference
Native cardiac valve
    1 29/F HOCM Not reported Dental Penicillin, erythromycin, gentamicin, rifampin Cure 15
    2 39/M Bicupsid AV AV Dental AVR Cure 20
    3 74/M None AV Dental AVR Cure 17
    4 55/M Prior IE AV Dental AVR Cure 2
    5 N/A Bicupsid AV AV Not reported Not specified Not reported 17
    6 54/M None AV Dental AVR Cure 11
    7 73/F NA AV, MV Colon cancer AVR, MVR Died (CHF) 18
    8 64/M None AV, MV Dental MVR, AVR Cure 24
    9 66/M None AV, MV Not reported Penicillin, netilmicin Cure 28
    10 32/M None AV, MV Intravenous drug user MVR, AVR Died (cardio- genic shock) 26
    11 48/M None MV Dental Vancomycin Cure 22
    12 9/F None MV Dental Penicillin Cure 12
    13 75/M Rheumatic heart disease MV Not reported Penicillin, gentamicin, teicoplainin, rifampin, erythromycin Cure 19
    14 38/M None MV Sigmoidoscopy Penicillin, gentamicin Cure 24
    15 60/M None MV Vascular graft Penicillin, rifampin Cure 8
    16 41/F None MV Dental Penicillin, gentamicin Cure 3
    17 42/M MR MV, TV Toxic syndrome Penicillin, streptomycin Cure 7
    18 74/M None TV Colon resection Penicillin, ceftriaxone, amikacin Cure 1
    19 71/M None TV Dental Penicillin Cure 21
    20 19/M None TV Intravenous drug user Penicillin, gentamicin Cure 4
    21 31/M Tetralogy of Fallot TV Not reported Vancomycin, rifampin Cure 5
Prosthetic valve
    22 84/F Bioprosthetic (porcine) MV, AV Not reported Penicillin, gentamicin Cure 14
    23 44/M Mechanical (St. Jude) MV Drug abuser Ceftriaxone, gentimicin Cure Present case
a

Abbreviations: AV, aortic valve; AVR, aortic valve replacement; CHF, congestive heart failure; HOCM, hypertrophic obststructive cardiomyopathy; MR, mitral regurgitation; MV, mitral valve; MVR, mitral valve replacement; TV, tricupsid valve; IE, infective endocarditis; NA, not available.

The patient ages ranged from 9 to 84 years (mean, 53 years), and most were males (Table 1). Predisposing factors included poor dental hygiene, dental procedures, and colon disease and gastrointestinal diagnostic procedures. Underlying intracardiac lesions included preexisting valvular lesions, congenitally bicuspid aortic valve (17, 20), hypertrophic cardiomyopathy (15), cardiac myxoma (27a), and tetralogy of Fallot (5). The aortic, tricuspid, and mitral valves have been affected.

To the best of our knowledge, there has been only one previous report of endocarditis due to Gemella morbillorum involving a prosthetic valve and only two cases associated with intravenous drug users.

In the majority of the reported cases of endovascular infections by Gemella morbillorum, a bacteriological cure was achieved with a combination of penicillin and an aminoglycoside. In patients that were either allergic or resistant to penicillin, vancomycin or a combination of erythromycin and rifampin has been effective (19).

In seven previously reported cases, native-valve endocarditis due to Gemella morbillorum was treated with surgical valve replacement (2, 11, 17, 18, 20, 24, 26). Two patients died shortly after aortic and mitral valve replacement (14, 26), but the remaining five cases had satisfactory outcomes.

To the best of our knowledge, our patient is only the second reported case of endocarditis due to Gemella morbillorum in a patient with a prosthetic valve and only the third in an intravenous drug abuser.

Despite severe valvular and paravalvular complications, the patient was stable 6 months after discharge although he received no surgical therapy. This unusual recovery demonstrates a dramatic response of endocarditis due to Gemella morbillorum to antimicrobial therapy.

REFERENCES

  • 1.Abboud, R., and A. Friart. 1995. Deux cas d'endocadite tricuspidienne isolee après intervention colique. Acta Clin. Belg. 50:242-245. [DOI] [PubMed] [Google Scholar]
  • 2.Akiyama, K., N. Taniyasu, J. Hirota, Y. Iba, and K. Maisawa. 2001. Recurrent aortic valve endocarditis caused by Gemella Morbillorum. Jpn Circ. J. 65:997-1000. [DOI] [PubMed] [Google Scholar]
  • 3.Al Soub, H., S. S. El-Shafie, A. L. Al-Khal, and A. M. Salam. 2003. Gemella morbillorum endocarditis. Saudi Med J. 24:1135-1137. [PubMed] [Google Scholar]
  • 4.Bell, E., and A. C. McCartney. 1992. Gemella morbillorum endocarditis in an intravenous drug abuser. J. Infect. 25:110-112. [DOI] [PubMed] [Google Scholar]
  • 5.Benes, J., D. Picha, M. Kabelkova, O. Dzupova, and B. Horova. 2002. Infective endocarditis caused by unusual gram-positive pathogens. Folia Microbiol. 47:737-741. [DOI] [PubMed] [Google Scholar]
  • 6.Brook, I., and E. H. Frazier. 1994. Microaerophilic streptococci as a significant pathogen: a twelve-year review. J. Med. 25:129-144. [PubMed] [Google Scholar]
  • 7.Calopa, M., F. Rubio, M. Aguilar, and J. Peres. 1990. Giant basilar aneurysm in the course of subacute bacterial endocarditis. Stroke 21:1625-1627. [DOI] [PubMed] [Google Scholar]
  • 8.Coto, H., and S. L. Berk. 1984. Endocarditis caused by Streptococcus morbillorum. Am. J. Med. Sci. 287:54-58. [DOI] [PubMed] [Google Scholar]
  • 9.Debast, S. B., R. Koot, and C. A. Meis. 1993. Infections caused by Gemella morbillorum. Lancet 342:560. [PubMed] [Google Scholar]
  • 10.Elting, L. S., G. P. Bodey, and B. H. Keefe. 1992. Septicemia and shock syndrome due to viridians streptococci: a case-control study of predisposing factors. Clin. Infect. Dis. 14:1201-1207. [DOI] [PubMed] [Google Scholar]
  • 11.Espinosa-Villarreal, J. G., E. Gonzalez-Reimers, M. Lecuona, M. Rodriguez-Gaspar, A. M. Lopez-Lirola, F. Rodriguez-Moreno, F. Santolaria, and C. Revert. 2000. Endocarditis caused by Gemella morbillorum. Enferm. Infecc. Microbiol. Clin. 18:293. [PubMed] [Google Scholar]
  • 12.Farmaki, E., E. Roilides, E. Darilis, M. Tsivitanidou, et al. 2000. Gemella morbillorum endocarditis in a child. Pediatr. Infect. Dis. J. 19:751-753. [DOI] [PubMed] [Google Scholar]
  • 13.Garavelli, P. L. 1990. Meningitis caused by Streptococcus morbillorum. Minerva Med. 81:69. [PubMed] [Google Scholar]
  • 14.Holland, J., R. Wilson, and N. Cumpston. 1996. Gemella morbillorum prosthetic valve endocarditis. N Z Med. J. 27:367. [PubMed] [Google Scholar]
  • 15.Kerr, J. R., C. H. Webb, J. G. McGimpsey, and N. P. S. Campbell. 1994. Infective endocarditis due to Gemella morbillorum complicating hypertrophic obstructive cardiomyopathy. Ulster Med. J. 63:108-110. [PMC free article] [PubMed] [Google Scholar]
  • 16.Kilpper-Balz, R., and K. H. Schleifer. 1988. Transfer of Streptococcus morbillorum to the genus Gemella as Gemella morbillorum comb. nov. Int. J. Syst. Bacteriol. 38:442-443. [Google Scholar]
  • 17.La Scola, B., and D. Raoult. 1998. Molecular identification of Gemella species from three patients with endocarditis. J. Clin. Microbiol. 36:866-871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lopez-Dupla, M., C. Creus, O. Navarro, and X. Raga. 1996. Association of Gemella morbillorum endocarditis with adenomatous polyps and carcinoma of the colon. Case report and review. Clin. Infect. Dis. 22:379-380. [DOI] [PubMed] [Google Scholar]
  • 19.Martin, M. J., D. A. Wright, and A. R. R. Jones. 1995. A case of Gemella morbillorum endocarditis. Postgrad. Med. J. 71:188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Maxell, S. 1989. Endocarditis due to Streptococcus morbillorum. J. Infect. 18:67-72. [DOI] [PubMed] [Google Scholar]
  • 21.Nandakumar, R., and G. Raju. 1997. Isolated tricuspid valve endocarditis in nonaddicted patients. A diagnostic challenge. Am. J. Med. Sci. 314:207-212. [DOI] [PubMed] [Google Scholar]
  • 22.Omran, Y., and C. A. Wood. 1993. Endovascular infection and septic arthritis caused by Gemella morbillorum. Diagn. Microbiol. Infect. Dis. 16:131-134. [DOI] [PubMed] [Google Scholar]
  • 23.Pradeep, R., M. Ali, and C. F. Encarnacion. 1997. Retropharyngeal abscess due to Gemella morbillorum. Clin. Infect. Dis. 24:284-285. [DOI] [PubMed] [Google Scholar]
  • 24.Terada, H., K. Miyahara, H. Sohara, M. Sonoda, H. Uenomachi, J. Sanada, et al. 1994. Infective endocarditis caused by an indigenous bacterium (Gemella morbillorum). Intern. Med. 33:628-631. [DOI] [PubMed] [Google Scholar]
  • 25.Tunnicliff, R. 1917. The cultivation of a micrococcus from blood in pre- and eruptive stages of measles. JAMA 68:1028-1030. [Google Scholar]
  • 26.Ubeda, R. P., M. I. Gutierrez, G. P. Ramirez, B. C. Perez, and S. M. Gobernado. 2000. Endocarditis due to Gemella morbillorum in a parenteral drug-abuse addict. Rev. Clin. Esp. 200:176-177. [DOI] [PubMed] [Google Scholar]
  • 27.von Essen, R., M. Ikavalko, and B. Forsblom. 1993. Isolation of Gemella morbillorum from joint fluid. Lancet 342:177-178. [DOI] [PubMed] [Google Scholar]
  • 27a.Wang, T.-D., S.-C. Chang, I.-P. Chiang, K.-T. Luh, and Y.-T. Lee. 1996. Infected left atrial myxoma caused by Gemella morbillorum. Scand. J. Infect. Dis. 28:633-634. [DOI] [PubMed] [Google Scholar]
  • 28.Woo, P. C., S. K. Lau, A. M. Fung, S. K. Chiu, R. W. Yung, and K. Y. Yuen. 2003. Gemella bacteraemia characterized by 16S ribosomal RNA gene sequencing. J. Clin. Pathol. 56:690-693. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES